Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
796
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes
Dina Abushanaba Department of Pharmacy, Hamad Medical Corporation, Doha, Qatarhttps://orcid.org/0000-0002-4162-8617
, Salma Chbiba Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar
, Rasha Kaddouraa Department of Pharmacy, Hamad Medical Corporation, Doha, Qatarhttps://orcid.org/0000-0003-2613-9759
, Moza Al Haila Department of Pharmacy, Hamad Medical Corporation, Doha, Qatarhttps://orcid.org/0000-0003-4991-982X
, Palli Valappila Abdul Roufa Department of Pharmacy, Hamad Medical Corporation, Doha, Qatarhttps://orcid.org/0000-0002-6924-8245
, Wessam El Kassema Department of Pharmacy, Hamad Medical Corporation, Doha, Qatarhttps://orcid.org/0000-0003-2145-7555
, Jassim Shahb Department of Cardiology, Hamad Medical Corporation, Doha, Qatar
, Ramesh Kumar Ravindran Nairb Department of Cardiology, Hamad Medical Corporation, Doha, Qatar
& Daoud Al-Badriyehc College of Pharmacy, QU Health, Qatar University, Doha, QatarCorrespondence[email protected]
https://orcid.org/0000-0001-7791-954X
show allhttps://orcid.org/0000-0001-7791-954X
Pages 404-417
|
Received 04 Oct 2023, Accepted 20 Feb 2024, Published online: 11 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.